UPDATE 1-Allergan's acute migraine treatment wins U.S. FDA approval
December 23, 2019 at 15:26 PM EST
The U.S. Food and Drug Administration said on Monday it had approved Allergan Plc's drug for relieving migraine headaches after their onset.
